By carefully cultivating strategic partnerships with distinguished industry leaders, we maximize growth opportunities for all our customers in their respective markets.
In July 2015, Appriss Health announced a partnership with Cerner to include NarxCare (NarxCheck) into the Cerner electronic health record (EHR) system. Embedding NarxCare within the Cerner EHR gives prescribers near real-time access to PDMP data and provides transparency to states to monitor compliance. Cerner is the only EHR supplier to package this process with one simple deployment.
Cerner’s health information technologies connect people, information and systems, at more than 18,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients’ clinical, financial and operational needs.
Cerner’s mission is to contribute to the systemic improvement of health care delivery and the health of communities. On February 2, 2015, Cerner Corporation acquired substantially all of the assets, and assumed certain liabilities, of the Siemens Health Services business from Siemens AG. Nasdaq: CERN. For more information about Cerner, visit www.cerner.com
Since 2011, Appriss has served as the technology provider for the National Association of Boards of Pharmacy (NABP). NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.
Founded in 1904, the National Association of Boards of Pharmacy (NABP) aims to ensure the public’s health and safety through its pharmacist license transfer and pharmacist competence assessment programs, as well as through its VIPPS, VAWD, and DMEPOS accreditation programs. In partnership between Appriss Health and NABP, PMP InterConnect® was launched in 2011 as an interstate data sharing “hub” for the exchange of Prescription Drug Monitoring (PDMP) data. PMPi currently processes more than 3.9 million requests and 8.2 million responses per month for consolidated multistate prescription drug monitoring program reports.
For more information about PMP InterConnect, visit the initiatives section of the NABP website.
Shatterproof, the American Society of Addiction Medicine (ASAM) and OpenBeds, an Appriss Health company, launched an online Addiction Treatment Needs Assessment. The online resource features a set of consumer-friendly, expert-developed questions to assess the needs of a person with addiction and produce guidance on the type of treatment that is most appropriate for them. The free resource is available nationwide and comes at a time when the COVID-19 pandemic has aggravated an already fragmented addiction treatment system in the U.S.
The thirteen-question assessment is available on www.treatmentconnection.com, an OpenBeds solution, www.Shatterproof.org/addictionassessment and www.asam.org for individuals or their loved ones to complete. It will be embedded within ATLAS, a new addiction treatment locator, analysis and standards website that will be available later this year. It is embedded at the OpenBeds Treatment Connection locator, a free portal which enables those seeking behavioral health treatment for themselves or others, to anonymously search for nearby providers, evaluate the type of care needed, and submit confidential online referral inquiries to appropriate treatment providers vetted by the state.
APPRISS HEALTH SOLUTIONS